share_log

8-K: Current report

8-K: Current report

8-K：重大事件
美股sec公告 ·  06/28 08:37
Moomoo AI 已提取核心信息
On June 27, 2024, Safety Shot, Inc. entered into a Securities Purchase Agreement with an accredited investor for the sale of 943,396 shares at $1.06 each, matching the closing price of that date, with no discounts or commissions involved. The transaction resulted in net proceeds of approximately $1 million for the company. Notably, the investor has close ties to the company's President, Jordan Schur, who owns a 15% stake in the investing entity and has family members who are also shareholders. This investment follows a previous $5 million investment from the same group in April 2024. The shares were issued in a private placement without prior registration, relying on exemptions from registration requirements. The company also issued a press release on June 28, 2024, detailing the investment and highlighting the President's confidence in the company's growth and product innovation. Safety Shot, Inc. is a wellness and dietary supplement company known for developing a patented product that aids in metabolizing blood alcohol content.
On June 27, 2024, Safety Shot, Inc. entered into a Securities Purchase Agreement with an accredited investor for the sale of 943,396 shares at $1.06 each, matching the closing price of that date, with no discounts or commissions involved. The transaction resulted in net proceeds of approximately $1 million for the company. Notably, the investor has close ties to the company's President, Jordan Schur, who owns a 15% stake in the investing entity and has family members who are also shareholders. This investment follows a previous $5 million investment from the same group in April 2024. The shares were issued in a private placement without prior registration, relying on exemptions from registration requirements. The company also issued a press release on June 28, 2024, detailing the investment and highlighting the President's confidence in the company's growth and product innovation. Safety Shot, Inc. is a wellness and dietary supplement company known for developing a patented product that aids in metabolizing blood alcohol content.
2024年6月27日，Safety Shot公司与认证投资者签署了一份证券购买协议，以每股1.06美元的价格出售了943,396股股票，与当日的收盘价相符，没有任何折扣或佣金。本次交易结果为该公司带来了约100万美元的净收益。值得注意的是，投资者与该公司的总裁乔丹·舒尔有密切联系，后者拥有投资实体15%的股权，并有家庭成员也是股东。此次投资是在该组织于2024年4月进行的500万美元之前投资的基础上进行的。股票是通过定向增发发行的，没有事先进行注册，依赖于豁免要求进行。同时，该公司还在2024年6月28日发布了新闻稿，详细介绍了这一投资，并强调总裁对公司的成长和产品创新的信恳智能。Safety Shot公司是一家以开发帮助代谢血液中酒精浓度的专利产品而闻名的健康和膳食补充剂公司。
2024年6月27日，Safety Shot公司与认证投资者签署了一份证券购买协议，以每股1.06美元的价格出售了943,396股股票，与当日的收盘价相符，没有任何折扣或佣金。本次交易结果为该公司带来了约100万美元的净收益。值得注意的是，投资者与该公司的总裁乔丹·舒尔有密切联系，后者拥有投资实体15%的股权，并有家庭成员也是股东。此次投资是在该组织于2024年4月进行的500万美元之前投资的基础上进行的。股票是通过定向增发发行的，没有事先进行注册，依赖于豁免要求进行。同时，该公司还在2024年6月28日发布了新闻稿，详细介绍了这一投资，并强调总裁对公司的成长和产品创新的信恳智能。Safety Shot公司是一家以开发帮助代谢血液中酒精浓度的专利产品而闻名的健康和膳食补充剂公司。
有用
没用

该公告为独立文件：

独立文件1  查看翻译

独立文件2  查看翻译

独立文件3  查看翻译

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息